Cell Death and Disease (Jul 2024)

Phase separation of RNF214 promotes the progression of hepatocellular carcinoma

  • Zheng-Jie He,
  • Ke He,
  • Song-Wang Cai,
  • Rui Zhang,
  • Zhong-Bao Shao,
  • Sheng-Te Wang,
  • Xiao-Peng Li,
  • Yan-Chi Li,
  • Wei-Jing Liu,
  • You-Qing Zhu,
  • Shi-Jie Zeng,
  • Yu-Bin Su,
  • Zhi Shi

DOI
https://doi.org/10.1038/s41419-024-06869-2
Journal volume & issue
Vol. 15, no. 7
pp. 1 – 13

Abstract

Read online

Abstract Hepatocellular carcinoma (HCC) is one of the most common malignant tumors, and the expression and function of an uncharacterized protein RNF214 in HCC are still unknown. Phase separation has recently been observed to participate in the progression of HCC. In this study, we investigated the expression, function, and phase separation of RNF214 in HCC. We found that RNF214 was highly expressed in HCC and associated with poor prognosis. RNF214 functioned as an oncogene to promote the proliferation, migration, and metastasis of HCC. Mechanically, RNF214 underwent phase separation, and the coiled-coil (CC) domain of RNF214 mediated its phase separation. Furthermore, the CC domain was necessary for the oncogenic function of RNF214 in HCC. Taken together, our data favored that phase separation of RNF214 promoted the progression of HCC. RNF214 may be a potential biomarker and therapeutic target for HCC.